Skip to main content

Discontinuation of tyrosine kinase inhibitors in CML patients in real-world clinical practice at a single institution

Access & Citations

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.